Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Izquierdo-Garcia (Donostia, Spain), L. Fadon (Donostia, Spain), M. Beraza (Donostia, Spain), U. Cossio (Donostia, Spain), J. Llop (Donostia, Spain), J. Ruiz-Cabello (Donostia, Spain). In-vivo lung molecular imaging of choline metabolism in a rat model of pulmonary arterial hypertension. 1422

Member's Comments

No comment yet.

Related content which might interest you: Heterogeneity in lung 18F-FDG uptake in precapillary pulmonary hypertension Source: International Congress 2019 – Pulmonary hypertension: clinical Year: 2019 Serotonin transporter genes, pulmonary haemodynamics and pulmonary hypertension Source: Annual Congress 2005 - Scientific year in review Year: 2005 Regulation of connexins by hypoxia in rat pulmonary vascular cells in an in vitro model of pulmonary hypertension Source: International Congress 2017 – Experimental PH Year: 2017 Two rat models of hemolysis-induced pulmonary hypertension Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Right ventricular interaction in pulmonary arterial hypertension Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension Year: 2008 An investigation of the origins of pulmonary artery lesion cells in pulmonary arterial hypertension rat models Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 Systemic oxygenation affects post-transplantation edema formation and pulmonary artery hypertension in an ex vivo animal model Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients Year: 2012 18-FDG uptake on PET-CT and metabolism in pulmonary arterial hypertension. Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 Non-invasive molecular imaging of pulmonary fibrosis Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease Year: 2018 Effects of treatment for pulmonary hypertension on pulmonary artery distensibility determined by cardiac magnetic resonance imaging Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007 Novel evaluation of pulmonary hypertension with chronic lung disease by perfusion SPECT/CT Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension Source: Eur Respir J 2009; 33: 1454-1466 Year: 2009 Autoradiography of hypoxia tracer in the pulmonary hypertensive rat heart Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Pulmonary arterial hypertension (PAH) in mice lacking the vasoactive intestinal polypeptide (VIP) gene: morphometric evidence for vascular remodeling Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Noninvasive estimation of PVR using contrast enhanced MRI in patients with idiopathic pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary circulation Year: 2009 Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study Source: Eur Respir J 2007; 29: 476-481 Year: 2007 Time-resolved study of endothelial shear-responsiveness in pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 A novel murine model of severe pulmonary arterial hypertension Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Combining physiology and imaging in the diagnosis of pulmonary hypertension Source: International Congress 2019 – Breathing disorders, cardiovascular disease and pulmonary embolism guidelines Year: 2019 Zamicastat decreases cardiac arrhythmias in a rat model of pulmonary arterial hypertension Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020